These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27739342)

  • 1. Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing.
    Eikrem OS; Strauss P; Beisland C; Scherer A; Landolt L; Flatberg A; Leh S; Beisvag V; Skogstrand T; Hjelle K; Shresta A; Marti HP
    Scand J Urol; 2016 Dec; 50(6):452-462. PubMed ID: 27739342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development.
    Eikrem O; Beisland C; Hjelle K; Flatberg A; Scherer A; Landolt L; Skogstrand T; Leh S; Beisvag V; Marti HP
    PLoS One; 2016; 11(2):e0149743. PubMed ID: 26901863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis.
    Landolt L; Eikrem Ø; Strauss P; Scherer A; Lovett DH; Beisland C; Finne K; Osman T; Ibrahim MM; Gausdal G; Ahmed L; Lorens JB; Thiery JP; Tan TZ; Sekulic M; Marti HP
    Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28596300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
    Li P; Conley A; Zhang H; Kim HL
    BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma.
    Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell Carcinoma.
    Strauss P; Marti HP; Beisland C; Scherer A; Lysne V; Leh S; Flatberg A; Koch E; Beisvag V; Landolt L; Skogstrand T; Eikrem Ø
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma.
    Li G; Feng G; Zhao A; Péoc'h M; Cottier M; Mottet N
    Biomarkers; 2017 Mar; 22(2):123-126. PubMed ID: 27775441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
    Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
    Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.
    Gu Y; Zou YM; Lei D; Huang Y; Li W; Mo Z; Hu Y
    Sci Rep; 2017 Oct; 7(1):14200. PubMed ID: 29079774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
    Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R
    Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
    Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
    Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
    Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
    Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of clear cell renal cell carcinoma by gene expression profiling.
    Thibodeau BJ; Fulton M; Fortier LE; Geddes TJ; Pruetz BL; Ahmed S; Banes-Berceli A; Zhang PL; Wilson GD; Hafron J
    Urol Oncol; 2016 Apr; 34(4):168.e1-9. PubMed ID: 26670202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.